Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 866

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Evidence of Artemisinin-Resistant Malaria in Africa

Open access
Balikagala, Betty, Fukuda, Naoyuki, Ikeda, Mie, Katuro, Osbert T., Tachibana, Shin-Ichiro, Yamauchi, Masato, Opio, Walter, Emoto, Sakurako, Anywar, Denis A., Kimura, Eisaku, Palacpac, Nirianne M.Q., Odongo-Aginya, Emmanuel I., Ogwang, Martin, Horii, Toshihiro, Mita, Toshihiro·2021·New England Journal of Medicine

Abstract

BACKGROUNDIn the six Southeast Asian countries that make up the Greater Mekong Subregion, Plasmodium falciparum has developed resistance to derivatives of artemisinin, the main component of first-line treatments for malaria.Clinical resistance to artemisinin monotherapy in other global regions, including Africa, would be problematic. METHODSIn this longitudinal study conducted in Northern Uganda, we treated patients who had P. falciparum infection with intravenous artesunate (a water-soluble artemisinin derivative) and estimated the parasite clearance half-life.We evaluated ex vivo susceptibility of the parasite using a ring-stage survival assay and genotyped resistancerelated genes. RESULTSFrom 2017 through 2019, a total of 14 of 240 patients who received intravenous artesunate had evidence of in vivo artemisinin resistance (parasite clearance halflife, >5 hours).Of these 14 patients, 13 were infected with P. falciparum parasites with mutations in the A675V or C469Y allele in the kelch13 gene.Such mutations were associated with prolonged parasite clearance half-lives (geometric mean, 3.95 hours for A675V and 3.30 hours for C469Y, vs. 1.78 hours for wild-type allele; P<0.001 and P = 0.05, respectively).The ring-stage survival assay showed a higher frequency of parasite survival among organisms with the A675V allele than among those with the wild-type allele.The prevalence of parasites with kelch13 mutations increased significantly, from 3.9% in 2015 to 19.8% in 2019, due primarily to the increased frequency of the A675V and C469Y alleles (P<0.001 and P = 0.004, respectively).Single-nucleotide polymorphisms flanking the A675V mutation in Uganda were substantially different from those in Southeast Asia. CONCLUSIONSThe independent emergence and local spread of clinically artemisinin-resistant P. falciparum has been identified in Africa.The two kelch13 mutations may be markers for detection of these resistant parasites.(Funded by the Japan Society for the Promotion of Science and others.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa2101746

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 866

Metadata

Authors
Balikagala, B., Fukuda, N., Ikeda, M., Katuro, O. T., Tachibana, S.-I., Yamauchi, M., Opio, W., Emoto, S., Anywar, D. A., Kimura, E., Palacpac, N. M. Q., Odongo-Aginya, E. I., Ogwang, M., Horii, T., & Mita, T.
Venue
New England Journal of Medicine
Published
2021-09-23
Volume
385
Issue
13
Pages
1163-1171
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W3200040377
Cited by
866
References
34
FWCI
119.17
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evidence of Artemisinin-Resistant Malaria in Africa. https://app.cochat.ai/papers/10.1056/nejmoa2101746
The paper
Balikagala, B., Fukuda, N., Ikeda, M., Katuro, O. T., Tachibana, S.-I., Yamauchi, M., Opio, W., Emoto, S., Anywar, D. A., Kimura, E., Palacpac, N. M. Q., Odongo-Aginya, E. I., Ogwang, M., Horii, T., & Mita, T. (2021). Evidence of Artemisinin-Resistant Malaria in Africa. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2101746

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.